A Clinically Supported Probiotic for Metabolic, Gastrointestinal, and Immune Health
”SBT2055” (Lactobacillus paragasseri ”SBT2055”) is a proprietary probiotic strain developed by Megmilk Snow Brand Co., Ltd. Extensive research has demonstrated its benefits for body fat management, intestinal health, and immune function. Backed by multiple human clinical studies, SBT2055 offers a science-based solution for dietary supplements, functional foods, and other health-promoting products.
Key Health Benefits
1. Reduction of Visceral Fat
Accumulation of visceral fat is closely associated with metabolic disorders and lifestyle-related diseases. Clinical studies have shown that daily intake of ”SBT2055” can significantly reduce visceral fat area in overweight individuals. By supporting healthier body composition, SBT2055 provides an attractive solution for consumers seeking effective weight management and metabolic health support.
Recommended daily intake: 1 billion CFU
2. Reduction of Subcutaneous Fat
In addition to reducing visceral fat, higher doses of ”SBT2055” have demonstrated the ability to decrease subcutaneous fat, which contributes to overall body shape and appearance. This makes ”SBT2055” particularly appealing for products targeting comprehensive fat reduction and healthy weight management.
Recommended daily intake: 100 billion CFU
3. Improvement of Intestinal Environment
A healthy gut microbiota plays a critical role in digestion, nutrient absorption, and overall well-being. ”SBT2055” helps improve the intestinal environment by supporting beneficial bacteria and promoting a balanced gut microbiome. Regular intake may contribute to improved digestive comfort and gastrointestinal health.
Recommended daily intake: 1 billion CFU
4. Regulation of Immune Function
The gut and immune system are closely interconnected. Research suggests that ”SBT2055” can help modulate immune responses and support the body's natural defense mechanis